PYRIMETHAMINE, LENALIDOMIDE, PANOBINOSTAT clinical trials

Optimizing reversal of HIV latency with combination therapy (pyrimethamine, lenalidomide, panobinostat)

This study is looking at a new combination of medicines to wake up 'sleeping' HIV in the body. By waking up the virus, the hope is that current treatments can then clear it more effectively. It's for adults with HIV-1, aiming to find better ways to manage the virus.